Literature DB >> 31102552

Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.

K Saipriya1, C H Swathi1, K S Ratnakar1, V Sritharan1.   

Abstract

Acinetobacter baumannii causes several nosocomial infections and poses major threat when it is multidrug resistant. Even pan drug-resistant strains have been reported in some countries. The intensive care unit (ICU) mortality rate ranged from 45.6% to 60.9% and it is as high as 84.3% when ventilator-associated pneumonia was caused by XDR (extensively drug resistant) A. baumannii. Acinetobacter baumannii constituted 9.4% of all Gram-negative organisms throughout the hospital and 22.6% in the ICUs according to a study carried out in an Indian hospital. One of the major factors contributing to drug resistance in A. baumannii infections is biofilm development. Quorum sensing (QS) facilitates biofilm formation and therefore the search for 'quorum quenchers' has increased recently. Such compounds are expected to inhibit biofilm formation and hence reduce/prevent development of drug resistance in the bacteria. Some of these compounds also target synthesis of some virulence factors (VF). Several candidate drugs have been identified and are at various stages of drug development. Since quorum quenching, inhibition of biofilm formation and inhibition of VF synthesis do not pose any threat to the DNA replication and cell division of the bacteria, chances of resistance development to such compounds is presumably rare. Thus, these compounds ideally qualify as adjunct therapeutics and could be administered along with an antibiotic to reduce chances of resistance development and also to increase the effectiveness of antimicrobial therapy. This review describes the state-of-art in QS process in Gram-negative bacteria in general and in A. baumannii in particular. This article elaborates the nature of QS mediators, their characteristics, and the methods for their detection and quantification. Various potential sites in the QS pathway have been highlighted as drug targets and the candidate quorum quenchers which inhibit the mediator's synthesis or function are enlisted.
© 2019 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Acinetobacter baumanniizzm321990; acyl homoserine lactones; biofilm; quorum quenching; quorum sensing

Mesh:

Substances:

Year:  2019        PMID: 31102552     DOI: 10.1111/jam.14330

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  20 in total

Review 1.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

2.  Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.

Authors:  Rajat Kumar Jha; Ekampreet Singh; Rameez Jabeer Khan; Ankit Kumar; Monika Jain; Jayaraman Muthukumaran; Amit Kumar Singh
Journal:  Mol Divers       Date:  2022-10-03       Impact factor: 3.364

3.  2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-N-oxide: the case of quorum sensing inhibitors.

Authors:  Truong Thanh Tung; Thang Nguyen Quoc
Journal:  RSC Med Chem       Date:  2021-09-08

Review 4.  Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors.

Authors:  Craig Miller; Jordon Gilmore
Journal:  Antibiotics (Basel)       Date:  2020-05-16

5.  Death from pan-resistant superbug.

Authors:  Larry Nichols
Journal:  Autops Case Rep       Date:  2019-07-19

6.  Quorum Sensing System-Regulated Proteins Affect the Spoilage Potential of Co-cultured Acinetobacter johnsonii and Pseudomonas fluorescens From Spoiled Bigeye Tuna (Thunnus obesus) as Determined by Proteomic Analysis.

Authors:  Xin-Yun Wang; Jing Xie
Journal:  Front Microbiol       Date:  2020-05-14       Impact factor: 5.640

7.  Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determine the Outcome?

Authors:  Camila Pimentel; Casin Le; Marisel R Tuttobene; Tomas Subils; Krisztina M Papp-Wallace; Robert A Bonomo; Marcelo E Tolmasky; Maria Soledad Ramirez
Journal:  Antibiotics (Basel)       Date:  2021-07-08

Review 8.  Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.

Authors:  Nilushi Indika Bamunuarachchi; Fazlurrahman Khan; Young-Mog Kim
Journal:  Curr Drug Targets       Date:  2021       Impact factor: 2.937

Review 9.  Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment.

Authors:  Soroosh Monem; Beata Furmanek-Blaszk; Adrianna Łupkowska; Dorota Kuczyńska-Wiśnik; Karolina Stojowska-Swędrzyńska; Ewa Laskowska
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 10.  Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.

Authors:  Dan Nie; Yue Hu; Zhou Chen; Mingkai Li; Zheng Hou; Xiaoxing Luo; Xinggang Mao; Xiaoyan Xue
Journal:  J Biomed Sci       Date:  2020-01-18       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.